Immuno-oncology has continued to be a priority for Big Pharma even during the heights of the Covid pandemic. Commetric’s infographic looks at the media debate around this rapidly developing field, taking into account key topics, companies, spokespeople, journalists and media outlets.
Recent Posts
- How Can Brands Avoid Pinkwashing During Pride and Beyond? A Media Analysis
- How Can PR and Comms Put the “S” in ESG? A Media Analysis
- Davos 2022: What Are the Key Takeaways for PR and Comms?
- Commetric Wins Diamond SABRE Award With Novartis
- Telehealth: Is Telemedicine a Trend to Stay After Its Covid Boom?
Tags
AMEC
Awards
Brand management
Climate Change
Consumer Trends
Content Marketing
Corporate Communication
COVID-19 Business Impact Tracker
Crisis Management
Digital Marketing
Diversity and Inclusion
ESG
Facebook
Fashion
Fashion PR
Financial Services
Fintech
Food and Drink
Health & Wellness
Health and Wellness
Influencer Marketing
Influencer Network Analysis
Instagram
Media & Entertainment
Media Analytics
Media Intelligence
Media Monitoring
Non-Profit
Pharma
PR
PR Measurement
PR Strategy
Public Affairs
Public Relations
Regeneration
Reputation Management
SABRE
Social Media
Social Media Analytics
Social Media Marketing
Storytelling
Strategic Communications
Sustainability
Technology
Twitter